---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-278529"
form_type: "8-K"
ticker: "BNTC"
cik: "0001808898"
company_name: "Benitec Biopharma Inc."
filed_at: "2024-12-13T23:59:59+00:00"
generated_at: "2026-05-29T03:41:15.714958+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Benitec appoints Sophie Mukadam as COO, Megan Boston as CFO; grants stock options to executives

## Summary
- Sophie Mukadam appointed COO effective Jan 1, 2025; base salary $500K, target bonus 40%.
- Megan Boston confirmed as Secretary and CFO effective Jan 1, 2025; continues as principal financial/accounting officer.
- CEO Jerel Banks granted options for 2.31M shares at $12.18, vesting quarterly over four years.
- CFO Megan Boston granted options for 720K shares at same price/vesting schedule.
- Base salaries increased: CEO to $667K, CFO to $415K, effective Jan 1, 2025; target bonuses 55% and 40%.

## SEC filing metadata
- accession: 0001193125-24-278529
- form_type: 8-K
- ticker: BNTC
- cik: 0001808898
- company_name: Benitec Biopharma Inc.
- filed_at: 2024-12-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808898/000119312524278529/0001193125-24-278529-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808898/000119312524278529/d853112d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-278529
- JSON: https://secwatch.observer/filing/0001193125-24-278529.json
- Plain text: https://secwatch.observer/filing/0001193125-24-278529.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.